// App-Quantinova.ai

M4012 2016 AHA : Differences in Utilization of Anti-Thrombotic Therapies and Invasive Cardiac Procedures for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the ACTION Registry - GWTG

Researchers

Presenter

  • Di Lu

Principal Investigators

  • Joseph Lucas

  • Abhinav Goyal

  • J. Lee Garvey

  • Tracy Y Wang

  • Shaun G Goodman

  • Matthew T Roe

Medical Centers

  • Duke Clinical Research Institute, Durham, NC

  • Rollins School of Public Health, Atlanta, GA

  • St. Michael's Hosp, Toronto, ON, Canada

  • Carolinas Medical Center, Charlotte, NC

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Microvascular complications of diabetes 1

  • Chronic kidney disease

  • Myocardial infarction

  • Renal disease

  • End stage renal disease

Biomarkers

  • N/A

Drug/Treatment

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved